ASXNSB Patented Stem Cell Solutions for Complex Auto-Immune Disorders & Unmet Needs August 2025 TechKnow Invest Roadshow Nathan Smith – Chief Executive Officer 1 For personal use only Disclaimers For personal use only Presentation Information This presentation has been prepared by NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) based on information available to it as at the date of this presentation. The information in this presentation is provided in summary form and does not contain all information nece ...

"We are highly appreciative of receiving significant G-Rex Grant funding that will improve G-Rex centric manufacturing for our unique cell and gene therapy drug products. The willingness of our Minnesota neighbors, Wilson Wolf and Bio-Techne, to allocate financial resources to our University of Minnesota cell and gene therapy (CGT) programs and the CGT field as a whole is greatly appreciated," said Dr. Branden Moriarity. "The state of Minnesota has a long history of pioneering adoptive cell therapy efforts ...